000			02889nam a22002657a 4500
001			R000757
003			PILC
005			20240805151518.0
008			240805b |||||||| |||| 00| 0 eng d
040			_beng _cFEU-NRMF MEDICAL LIBRARY _drda
041			_aeng
050			_aOB 2023 0004
245			_aAssociation of factors with the use of oxytocin combined with other uterotonics versus oxytocin alone in the prevention of primary postpartum hemorrhage in a tertiary medical center from 2016 to 2019. / _b[principal investigator]: Dosado, Odessa L. [co-author]: Reyes, Lylah D.
260			_afairview, Quezon City: _bDepartment of OBgyne, FEU-NRMF, _c2023
300			_c(in folder) _ewith flash drive (soft copy)
336			_2rdacontent _atext
337			_2rdamedia _aunmediated
338			_2rdacarrier _avolume
504			_aIncludes bibliographical refernces.
520			_aABSTRACT Background: Active Management of Third Stage of Labor (AMTSL), includes prompt administration of uterotonic agents after delivery with oxytocin as first line agent to prevent uterine atony. However, there is an increasing trend with use of combination uterotonics for prevention of uterine atony even among low risk women. Objective: Determine the association of factors with the use of oxytocin combined with other uterotonics and oxytocin alone in prevention of primary postpartum hemorrhage in a tertiary medical center from 2016 to 2019 Methods: A four-year cross-sectional study which reviewed charts of women who delivered and were given single or combination uterotonics postpartum. Purposive sampling done. Analysis conducted separately for vaginal delivery and cesarean section. Data extracted included maternal- and obstetric-related factors, as well as uterotonic used and its adverse effects. Result: There were 450 charts of women with singleton pregnancies reviewed, 58.2% (262) had vaginal delivery while 41.7% (188) delivered by cesarean section. Combined uterotonics given to 42.4% (192) of cases, mostly among cesarean deliveries at 82.3% (158/192). Vaginal delivery cases with combined uterotonics showed significantly lower proportion of women with normal preoperative hematocrit (p 0.01). While for cesarean section, use of combined uterotonics was significantly higher among women with blood loss > 500 mL. No adverse effects and history of postpartum hemorrhage recorded. Conclusion: Combined uterotonics was commonly used for cesarean delivery. Factors associated the use of combined uterotonics in prevention of postpartum hemorrhage includes greater estimated blood loss and normal pre- operative hematocrit. Keywords: Uterotonics, Combination uterotonics, Oxytocin, Uterine atony, Postpartum hemorrhage.
521			_aisha _aRESDOG
700			_aDosado, Odessa L. _eprincipal investigator _eauthor
700			_aReyes, Lylah D. _eco-author
942			_2lcc _cRU
999			_c12950 _d12950